In NSCLC-derived cells, resistance to ChoKαIs is overcome by overexpression of acid ceramidase (ASAH1) in keeping with the known mechanism of action of ChoKαIs of inducing increased levels of ceramides [59,61] and allows the identification of tumours resistant to treatment with ChoKαIs. This evidence concerns the gene ASAH1 and non-small cell lung carcinoma.